PapersFlow Research Brief
HIV/AIDS Research and Interventions
Research Guide
What is HIV/AIDS Research and Interventions?
HIV/AIDS Research and Interventions is the body of scientific work focused on the prevention, treatment, and epidemiology of HIV/AIDS, encompassing antiretroviral therapy, preexposure prophylaxis, stigma and discrimination, viral load, mother-to-child transmission, adherence to medication, mortality rates, and health-related stigma.
This field includes 153,167 works on topics such as antiretroviral therapy and HIV transmission. Palella et al. (1998) in "Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection" showed that intensive antiretroviral therapies led to declines in AIDS-related morbidity and mortality. Cohen et al. (2011) in "Prevention of HIV-1 Infection with Early Antiretroviral Therapy" demonstrated that early antiretroviral therapy reduced sexual transmission of HIV-1 and clinical events.
Topic Hierarchy
Research Sub-Topics
Antiretroviral Therapy
This sub-topic examines the efficacy, regimens, and long-term outcomes of antiretroviral drugs in suppressing HIV replication and restoring immune function. Researchers study drug resistance, combination therapies, and strategies to optimize treatment in diverse populations.
Preexposure Prophylaxis
This sub-topic investigates PrEP strategies using antiretrovirals to prevent HIV acquisition in high-risk individuals. Researchers evaluate adherence, efficacy across populations, and implementation barriers in real-world settings.
HIV Mother-to-Child Transmission
This sub-topic focuses on interventions like zidovudine and combination prophylaxis to prevent vertical HIV transmission during pregnancy, delivery, and breastfeeding. Researchers analyze risk factors, neonatal outcomes, and global elimination strategies.
HIV Treatment Adherence
This sub-topic explores behavioral, psychosocial, and pharmacological factors influencing adherence to HIV medications. Researchers develop interventions to improve retention in care and address barriers like stigma and side effects.
HIV-Related Stigma and Discrimination
This sub-topic studies the social and psychological impacts of stigma on HIV testing, care engagement, and quality of life. Researchers evaluate anti-stigma interventions and their effects on epidemic control.
Why It Matters
HIV/AIDS research has enabled substantial reductions in mortality, as Palella et al. (1998) reported declining morbidity and mortality among patients with advanced HIV infection attributable to intensive antiretroviral therapies, with 9,455 citations reflecting its impact. Prevention strategies advanced through Grant et al. (2010), who found that oral FTC-TDF provided protection against HIV acquisition in men who have sex with men, correlating detectable blood levels with prophylactic effects in a trial funded by the National Institutes of Health and the Bill and Melinda Gates Foundation. Connor et al. (1994) established that zidovudine treatment reduced maternal-infant HIV transmission risk by approximately two-thirds in untreated pregnant women, influencing global guidelines for mother-to-child prevention. These interventions underpin public health strategies reducing transmission rates and improving survival across populations.
Reading Guide
Where to Start
"Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection" by Palella et al. (1998) first, as it provides foundational evidence on antiretroviral therapy's impact on survival, central to understanding treatment evolution.
Key Papers Explained
Palella et al. (1998) "Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection" established antiretroviral therapy's role in reducing deaths, cited 9,455 times. Cohen et al. (2011) "Prevention of HIV-1 Infection with Early Antiretroviral Therapy" built on this by showing early therapy prevents transmission in HPTN 052. Grant et al. (2010) "Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men" extended prevention to preexposure with FTC-TDF. Connor et al. (1994) "Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment" demonstrated vertical transmission reduction, informing guidelines like those in "Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents" (1998).
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Recent preprints explore CD8+ T cell stemness preceding post-intervention viraemia control, sustained HIV-1 remission via heterozygous CCR5Δ32 stem cell transplantation in Nature, and combination therapies for long-term control. News highlights amfAR's $2.4 million grants for HIV cure strategies across three continents and AAP's updated breastfeeding policy for people with HIV in the US.
Papers at a Glance
In the News
amfAR Awards $2.4 Million in New HIV Cure-Focused ...
NEW YORK, October 16, 2025 — amfAR, The Foundation for AIDS Research, announced a new round of grants Thursday to research teams across three continents targeting novel HIV cure strategies. It mark...
Positive Action Funding Opportunities
#### Innovator Funding Up to £100,000 over two years (£50,000 per year) * Investments into the testing and piloting of new approaches
Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional)
The NIMH invites applications for Research Project Grants (R01) that propose to advance innovative research to optimize HIV prevention, treatment, and care. Applications may include formative basic...
Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional)
The NIMH invites applications for Research Project Grants (R34) that propose formative research, intervention development, and pilot-testing of interventions; formative implementation research to i...
Aligning HIV/AIDS Receipt Dates with General Standard ...
# Aligning HIV/AIDS Receipt Dates with General Standard Receipt Dates to Simplify Application Processes and Reduce Burden for Researchers January 28, 2026
Code & Tools
Simpact Cyan is the C++ version of the Simpact family of programs. It is an agent based model (ABM) to study the way an infection spreads and can b...
`DataSpaceR` is an R interface to the CAVD\ DataSpace , a data sharing and discovery tool that facilitates exploration of HIV immunological data fr...
See also https://github.com/clinicedc/edc ## Installation To setup and run a test server locally You'll need mysql and Redis. Create the databa...
# # hiv Star ## Here are 99 public repositories matching this topic... _Language:_ All Filter by language
# About the OpenSAFELY framework The OpenSAFELY framework is a new secure analytics platform for electronic health records research in the NHS.
Recent Preprints
Current developments in HIV treatment and prevention
In this article, we provide an overview of the recent advancements in HIV prevention and treatment while highlighting areas that require attention. We examine the expanding variety of strategies th...
HIV
Research (652) News (537) Opinion (285) Case Report (177) Review (102) Letter (77) Patient Information (18) Humanities (12) Filter By Keyword - AAP Changes Its Breastfeeding Policy for Peo...
CD8 + T cell stemness precedes post-intervention control of HIV viraemia
Interventions to induce lasting human immunodeficiency virus (HIV) remission are needed to obviate the requirement for lifelong antiretroviral therapy. Durable post-intervention control (PIC) of vi...
Long-Term HIV Control: Could this Combination Therapy Be the Key?
### Topics * AIDS and HIV * Infectious Disease ## Recommended Reading Two researchers look at a screen showing microscopic images relevant to research on long COVID. * Research * Jan. 21, 2026 ...
Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation
*Nature* (2025) Cite this article * 43kAccesses * 1Citations * 905Altmetric * Metricsdetails ### Subjects * Stem-cell research * Viral infection ## Abstract
Latest Developments
Recent developments in HIV/AIDS research as of February 2026 include promising vaccine trials such as the first vaccinations in the Phase 1 IAVI G004 trial using immunogens delivered via mRNA platform, aiming to induce broadly neutralizing antibodies (IAVI, clinicaltrials.gov), and updated WHO guidelines reflecting significant advances in clinical management (WHO). Additionally, innovative interventions like long-acting injectable PrEP (lenacapavir) have shown high efficacy in preventing HIV infection (NEJM), and research into immunotherapies and vaccines continues to explore strategies for functional cures and immune control (Nature, Nature Communications).
Sources
Frequently Asked Questions
What caused declining morbidity and mortality in advanced HIV patients?
Palella et al. (1998) in "Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection" attributed recent declines in AIDS morbidity and mortality to the use of more intensive antiretroviral therapies. This study, published in the New England Journal of Medicine with 9,455 citations, tracked outcomes in patients receiving such treatments.
How does early antiretroviral therapy prevent HIV transmission?
Cohen et al. (2011) in "Prevention of HIV-1 Infection with Early Antiretroviral Therapy" showed that early initiation of antiretroviral therapy reduced rates of sexual transmission of HIV-1 and clinical events. The HPTN 052 trial indicated personal and public health benefits from this approach.
What is the effect of preexposure chemoprophylaxis in men who have sex with men?
Grant et al. (2010) in "Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men" found that oral FTC-TDF protected against HIV acquisition. Detectable blood levels strongly correlated with the prophylactic effect in the trial (ClinicalTrials.gov NCT00458393).
How effective is zidovudine in preventing mother-to-child HIV transmission?
Connor et al. (1994) in "Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment" reported that zidovudine given antepartum, intrapartum, and to the newborn for six weeks reduced transmission risk by approximately two-thirds in pregnant women with mildly symptomatic HIV and no prior treatment.
What classification system is used for HIV infection?
Castro et al. (1993) in "1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults" revised the system to emphasize the clinical importance of CD4+ T-lymphocyte count in categorizing HIV-related conditions, replacing the 1986 CDC system.
What methods study hidden populations like those at risk for HIV?
Heckathorn (1997) in "Respondent-Driven Sampling: A New Approach to the Study of Hidden Populations" introduced respondent-driven sampling for populations without sampling frames where membership is threatening, improving response rates and candor over standard probability methods.
Open Research Questions
- ? How can interventions induce lasting HIV remission without lifelong antiretroviral therapy, as explored in post-intervention control of viraemia?
- ? What combination therapies enable sustained HIV-1 remission, such as heterozygous CCR5Δ32 stem cell transplantation?
- ? How do CD8+ T cell stemness factors contribute to post-intervention control of HIV viraemia?
- ? What new strategies address gaps in HIV prevention and treatment implementation?
- ? How can treatment adherence be optimized using frameworks like Rubin's Four Tendencies in HIV contexts?
Recent Trends
Fields show 153,167 works with growth data unavailable, but recent preprints address HIV cure via stem cell transplantation and T cell interventions. amfAR awarded $2.4 million on October 16, 2025, for novel HIV cure strategies across three continents.
NIMH funding opportunities emerged in January 2026 for optimizing HIV prevention and care continuum outcomes through R01 and R34 grants.
Research HIV/AIDS Research and Interventions with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching HIV/AIDS Research and Interventions with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers